ZEISS Ventures and M2Care invest in Maculaser to advance temperature-controlled retinal laser therapy
Helsinki, 28 May 2026 ZEISS Ventures has joined Maculaser’s latest funding round, co-led together with M2Care. The investment marks the […]
Nature Communications publishes ERG-guided, temperature-controlled retinal laser study
Researchers at Aalto University, Karolinska Institutet / St. Erik Eye Hospital, and the University of Helsinki demonstrate that real-time electroretinography
Nature Communications publishes ERG-guided, temperature-controlled retinal laser study Read more ›
Maculaser Joins €32M EU-Funded PhotonMed Initiative to Advance Retinal Care with Photonics
We are proud to announce that Maculaser is now part of PhotonMed, a €32 million European Union (Chips Joint Undertaking,
New Clinical Trial Manager joins Maculaser
We are pleased to announce that Aki Vartiainen joins the Maculaser team as Clinical Trial Manager.Aki brings strong expertise to our
New Clinical Trial Manager joins Maculaser Read more ›
Maculaser secures its first Japanese patent
Maculaser has been granted a Japanese patent for its method and device for determining changes in retinal and/or brain temperature.
Maculaser secures its first Japanese patent Read more ›
Maculaser’s retinal treatment technology exhibited in Media
Finnish new technology focused magazine T&T (Tekniikka ja Talous) reports on Maculaser’s goals and timeline in developing novel treatments for
Maculaser’s retinal treatment technology exhibited in Media Read more ›
New Head of Regulatory Affairs and Quality Assurance joins the team
We are excited to announce that Kirsty Happonen joins the Maculaser team as Head of Regulatory Affairs and Quality Assurance. Kirsty
New Head of Regulatory Affairs and Quality Assurance joins the team Read more ›
General Application
We are seeking talented professionals to advance our mission of preventing blindness
General Application Read more ›
A preclinical study validates the treatment mechanism and feasibility
The paper discusses a new heat treatment for the retina that uses a special method, based on the bioelectrical response
A preclinical study validates the treatment mechanism and feasibility Read more ›